Skip to Content
Merck
CN
  • Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.

Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.

Therapeutic drug monitoring (1981-01-01)
T B Vree, Y A Hekster, J E Damsma, R van Dalen, J C Hafkenscheid, W T Friesen
ABSTRACT

Plasma and urine concentrations of creatinine, sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole were measured in patients with varying degrees of kidney impairment. The plasma elimination half-life of sulphamethoxazole is not influenced by the kidney function, while the half-life of the metabolite is fully dependent on the kidney function. The renal clearances of the metabolites and that of the parent compound under alkaline urine conditions are linearly related to the creatinine clearance. Kidney impairment affects only the renal clearance of the metabolite, whereas sulphamethoxazole is metabolized (acetylated) independently of kidney function.

MATERIALS
Product Number
Brand
Product Description

Sulfamethoxazole impurity A, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity